That plus the longstanding safety profile (#msg-62332894) ensure that US Copaxone sales will never fall off a cliff, no matter how many of the oral MS drugs end up being approved in the next few years.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.